Tizanidine is an effective muscle relaxant commonly prescribed to treat muscle spasms and pain caused by certain medical conditions. The drug has been in use since the early 1990s and has been known to be generally safe and well tolerated. However, as with any medication, there are potential side effects associated with tizanidine. This article will discuss the various side effects associated with tizanidine, as well as tips for managing them.
The most common side effects associated with tizanidine are drowsiness, dizziness, dry mouth, nausea, and weakness. These side effects are usually mild and do not require medical attention. However, if they become severe or persist, it is important to contact your doctor.
Less common side effects associated with tizanidine include confusion, hallucinations, depression, difficulty breathing, and heart palpitations. If any of these side effects occur, it is important to seek medical attention immediately.
In rare cases, tizanidine can cause serious side effects such as chest pain, fainting, irregular heartbeat, and seizures. If any of these side effects occur, it is important to seek medical attention immediately.
The best way to manage tizanidine side effects is to take the medication as prescribed by your doctor. It is important to take the medication exactly as prescribed and not to take more or less than prescribed. Additionally, it is important to avoid activities that may cause drowsiness or dizziness, such as driving or operating heavy machinery.
Tizanidine is an effective muscle relaxant that is generally safe and well tolerated. However, as with any medication, there are potential side effects associated with tizanidine. It is important to be aware of the potential side effects and to seek medical attention if any of them occur. The best way to manage tizanidine side effects is to take the medication as prescribed and to avoid activities that may cause drowsiness or dizziness.
1.
NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.
2.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
3.
FDA Expands Durvalumab Label to Operable Lung Cancer
4.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
5.
There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.
1.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
2.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
3.
Unveiling the Hidden Benefits of Lymphedema Treatment
4.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
5.
Florinef: Understanding Its Uses and Side Effects
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation